Key Factors To Consider To Ensure Effective Management of a 340B Pharmacy Program

It’s becoming increasingly difficult for Covered Entities (CEs) to effectively manage their 340B pharmacy programs. Often times understaffed relative to the task of handling the myriad of challenges that come with managing a 340B program, they face a seemingly constant barrage of maneuvering and attacks aimed at reducing their 340B benefit. In response, many Covered Entities are evaluating new strategies to strengthen or reinvigorate their program.

Read More »

Summitt – A Powerful Partnership Between Respected 340B Experts Providing Unparalleled Integrity and Audit Services

We are excited to announce that Assent Consulting and Washington D.C. based-Powers Law, the leading 340B law firm, have partnered together to develop a groundbreaking compliance offering – Summitt. This program is being extended to community health centers and clinics across the nation, delivering compliance confidence.

Read More »

5 Steps to Capturing 340B Referral Prescriptions–And Why Covered Entities Should Consider It

Referral prescriptions can be an important additional source of 340B funding for covered entities (CEs). However, it wasn’t until recently that referral prescriptions moved out of the “grey area” of 340B and into the mainstream. Just three years ago, most CEs avoided this area due to operational and compliance concerns. Today, many CEs have already added referral prescription capture to their 340B programs or are actively evaluating solutions.

Read More »

A Recap of the Acentrus Specialty Conference

Acentrus Specialty hosted its first Acentrus Specialty Conference on January 12-13, 2021, which brought together pharmacists, manufacturers, and suppliers to examine the challenges, opportunities, and best practices in advancing health system specialty pharmacy practice. A pharmacy paradigm shift is under way, as Integrated Delivery Networks (IDNs) are partnering to grow their specialty pharmacy operations.

Read More »